Payden Equity Income Fund Adviser Cl
PYVAX · NASDAQ
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | – | – |
| Revenue | $9,197 | $10,492 | $10,521 | $11,575 |
| % Growth | -12.3% | -0.3% | -9.1% | – |
| Gross Profit | $9,197 | $10,492 | $10,521 | $11,575 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $109,436 | -$104,354 | $139,446 | $61,706 |
| % Margin | 1,189.9% | -994.6% | 1,325.4% | 533.1% |
| Net Income | $111,628 | -$101,493 | $142,370 | $66,706 |
| % Margin | 1,213.7% | -967.4% | 1,353.2% | 576.3% |
| EPS Diluted | 2.77 | -2.53 | 3.62 | 1.7 |
| % Growth | 209.5% | -169.9% | 112.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |